Latest Lead News

Rapid Critical Metals has obtained a five-year BC Mines Act Permit for its Prophet River Project in Canada, enabling a maiden drilling campaign targeting critical gallium and germanium deposits amid global supply concerns.

Aurelia Metals has completed a Pre-Feasibility Study for its New Occidental Tailings Retreatment Project, declaring a maiden Ore Reserve and outlining strong economics and a clear path to production at its Peak Operation in NSW.

OD6 Metals reveals multi-element assay results from its Quinn Fluorspar Project showing exceptionally low impurities and high fluorspar grades, supporting potential direct shipping Metspar and upgraded AcidSpar products.

Nanoveu’s EMASS technology achieves real-time, always-on keyword spotting using bone-conduction vibration on the ECS-DoT edge AI chip at under 1 milliwatt power, eliminating the need for microphones and overcoming key challenges in wearable voice interfaces.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

Charter Hall Social Infrastructure REIT (CQE) has acquired a 25% interest in a $53 million Brisbane pathology lab leased to Sonic Healthcare under a 20-year triple-net lease, while divesting early learning assets and reaffirming FY26 guidance.

FBR Ltd is set to slash its share count by consolidating every 50 securities into one, impacting ordinary shares, performance rights, and options. The move awaits shareholder approval with critical milestones scheduled throughout July 2026.

Vita Resources has raised $2.9 million through a heavily supported share placement to accelerate exploration at its Australian and Canadian projects, while pursuing new gold and critical minerals opportunities.

Hydralyte USA secures A$392,000 through a share placement, appoints two new non-executive directors, and implements significant cost reductions following CEO resignation as it targets cash-flow break-even and strategic expansion.

Eclipse Metals has unveiled high-grade fluorite alongside a suite of critical minerals including gallium and rubidium at Greenland’s Ivigtût mine, repositioning the asset beyond its historic cryolite legacy.

Perseus Mining has boosted its on-market share buy-back program by A$50 million to A$150 million, reflecting confidence in its balance sheet and cash flow generation while maintaining funding for organic growth.

Paradigm Biopharmaceuticals has completed enrolment ahead of schedule in its pivotal Phase 3 trial for Zilosul®, enrolling 538 patients with knee osteoarthritis and maintaining its timeline for interim and final results.